Abstract
Seventy-nine patients with advanced breast cancer were tested for the presence, in serum, of a 110 kDa soluble, c-erbB-2 fragment. Thirty-nine patients were seropositive. There was no correlation between seropositivity and menopausal status, or with oestrogen status. In addition, no correlation could be found between tissue c-erbB-2 immunostaining for the external domain of the c-erbB-2 receptor and the presence of soluble c-erbB-2 in serum. The presence of serum soluble c-erbB-2, however, had a significant impact on survival of patients with advanced disease, suggesting that this test may become a useful independent prognostic indicator.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kandl, H., Seymour, L. & Bezwoda, W. Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer. Br J Cancer 70, 739–742 (1994). https://doi.org/10.1038/bjc.1994.387
Issue Date:
DOI: https://doi.org/10.1038/bjc.1994.387
This article is cited by
-
The extracellular domain of Her2 in serum as a biomarker of breast cancer
Laboratory Investigation (2018)
-
Serum HER2 levels determined by two methods in patients with metastatic breast cancer
International Journal of Clinical Oncology (2012)
-
Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer
Breast Cancer Research and Treatment (2009)
-
Preoperative serum levels of c-erbB-2 do not seem to be useful in management of patients with rectal cancer
International Journal of Colorectal Disease (2007)
-
A sensitive and high-throughput assay to detect low-abundance proteins in serum
Nature Medicine (2006)